4-[(7-Bromo-2-methyl-4-oxo-3,4-dihydro-quinazolin-6-ylmethyl)-prop-2-ynyl-amino]-N-pyridin-3-ylmethyl-benzamide

ID: ALA123446

Cas Number: 206275-15-2

PubChem CID: 135528987

Product Number: C125837, Order Now?

Max Phase: Preclinical

Molecular Formula: C26H22BrN5O2

Molecular Weight: 516.40

Molecule Type: Small molecule

Names and Identifiers

Synonyms: CB-30685

Canonical SMILES:  C#CCN(Cc1cc2c(O)nc(C)nc2cc1Br)c1ccc(C(=O)NCc2cccnc2)cc1

Standard InChI:  InChI=1S/C26H22BrN5O2/c1-3-11-32(16-20-12-22-24(13-23(20)27)30-17(2)31-26(22)34)21-8-6-19(7-9-21)25(33)29-15-18-5-4-10-28-14-18/h1,4-10,12-14H,11,15-16H2,2H3,(H,29,33)(H,30,31,34)

Standard InChI Key:  SHNBLWMBWXIKMR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    0.6292   -3.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0833   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6292   -3.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7875   -3.0792    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0833   -4.3167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7875   -3.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0542   -3.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3417   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3417   -4.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7750   -3.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0542   -3.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7667   -2.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4792   -3.0750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1875   -1.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8917   -1.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4875   -2.6542    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.9500   -3.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3042   -3.0750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0833   -1.8417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9917   -3.8667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.6042   -1.3917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5292   -2.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5375   -3.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7125   -2.3625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7167   -3.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9125   -2.6375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2042   -3.0542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7667   -4.3167    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
    3.4792   -2.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9000   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5083   -4.3167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3292   -1.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6292   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3417   -2.6250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  2  0
  4  2  2  0
  5  3  1  0
  6  5  2  0
  7  8  2  0
  8  1  1  0
  9  3  1  0
 10 17  1  0
 11  7  1  0
 12  7  1  0
 13 12  1  0
 14 29  1  0
 15 14  3  0
 16 10  1  0
 17 23  2  0
 18 13  1  0
 19  2  1  0
 20 10  2  0
 21 30  2  0
 22 24  2  0
 23 25  1  0
 24 18  1  0
 25 18  2  0
 26 27  1  0
 27 16  1  0
 28 11  1  0
 29 13  1  0
 30 26  1  0
 31  6  1  0
 32 34  2  0
 33 26  2  0
 34 33  1  0
  9 11  2  0
  4  6  1  0
 22 17  1  0
 21 32  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA123446

   CB30865

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 516.40

Molecular Weight (Monoisotopic): 515.0957

AlogP: 4.37

#Rotatable Bonds: 7

Polar Surface Area: 91.24

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 12.77

CX Basic pKa: 4.82

CX LogP: 4.74

CX LogD: 4.74

Aromatic Rings: 4

Heavy Atoms: 34

QED Weighted: 0.35

Np Likeness Score: -1.62

References

1. Bavetsias V, Skelton LA, Yafai F, Mitchell F, Wilson SC, Allan B, Jackman AL..  (2002)  The design and synthesis of water-soluble analogues of CB30865, a quinazolin-4-one-based antitumor agent.,  45  (17): [PMID:12166942] [10.1021/jm011081s]

2. Lockman JW, Murphy BR, Zigar DF, Judd WR, Slattum PM, Gao ZH, Ostanin K, Green J, McKinnon R, Terry-Lorenzo RT, Fleischer TC, Boniface JJ, Shenderovich M, Willardsen JA..  (2010)  Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt).,  53  (24): [PMID:21080724] [10.1021/jm101145b]

3. Galli U, Travelli C, Massarotti A, Fakhfouri G, Rahimian R, Tron GC, Genazzani AA..  (2013)  Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.,  56  (16): [PMID:23679915] [10.1021/jm4001049]

4. Christensen MK, Erichsen KD, Olesen UH, Tjørnelund J, Fristrup P, Thougaard A, Nielsen SJ, Sehested M, Jensen PB, Loza E, Kalvinsh I, Garten A, Kiess W, Björkling F..  (2013)  Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.,  56  (22): [PMID:24164086] [10.1021/jm4009949]

5. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani.  (2020)  Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen,  [10.6019/CHEMBL4495564]

6. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen.  (2020)  Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort,  [10.6019/CHEMBL4495565]

7. Institute for Molecular Medicine Finland - High Throughput Biomedicine Unit.  (2023)  ECBD screening data for assay EOS300108,  [10.6019/EOS300108]

Source

Source(3):

• Scientific Literature
• SARS-CoV-2 Screening Data 2020-21
• EU-OPENSCREEN dataset